| First Author | Maetens M | Year | 2007 |
| Journal | Blood | Volume | 109 |
| Issue | 6 | Pages | 2630-3 |
| PubMed ID | 17105817 | Mgi Jnum | J:143668 |
| Mgi Id | MGI:3828388 | Doi | 10.1182/blood-2006-03-013656 |
| Citation | Maetens M, et al. (2007) Distinct roles of Mdm2 and Mdm4 in red cell production. Blood 109(6):2630-3 |
| abstractText | Mdm2 and Mdm4 are critical negative regulators of the p53 tumor suppressor. Mdm4-null mutants are severely anemic and exhibit impaired proliferation of the fetal liver erythroid lineage cells. This phenotype may indicate a cell-intrinsic function of Mdm4 in erythropoiesis. In contrast, red blood cell count was nearly normal in mice engineered to express low levels of Mdm2, suggesting that Mdm2 might be dispensable for red cell production. Here, we further explore the tissue-specific functions of Mdm2 and Mdm4 in the erythroid lineage by intercrossing conditional Mdm4 and Mdm2 alleles to an erythroid-specific Cre (Er-GFP-Cre) knock-in allele. Our data show that Mdm2 is required for rescuing erythroid progenitors from p53-mediated apoptosis during primitive erythropoiesis. In contrast, Mdm4 is only required for the high erythropoietic rate during embryonic definitive erythropoiesis. Thus, in this particular cellular context, Mdm4 only contributes to p53 regulation at a specific phase of the differentiation program. |
